Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics ...( Presenters will Include World-R...)

Presenters will Include World-Renowned RNase and RNA Researchers

SOMERSET, N.J., Oct. 25 /PRNewswire-FirstCall/ -- The RNA interference- like mechanics of ribonuclease (RNase) therapeutics will be the focus of scientific presentations in a Nov. 29 Webinar hosted by Alfacell Corporation (Nasdaq: ACEL).

Moderated by Kuslima Shogen, D.Sc., Alfacell's chairman and chief executive officer, and David Sidransky, M.D., Alfacell's scientific advisory board chairman, the Webinar will feature presentations about the basics of RNases, how RNases cleave RNA to interfere with the cell cycle, and the potential clinical applications for RNase therapeutics. The panel of presenters will be comprised of world-renowned RNase and RNA researchers, including:

-- Susanna Rybak, Ph.D., whose research has centered on the biology of

RNases for more than 25 years. Her laboratory at the National Cancer

Institute developed the groundwork for RNase-based therapeutics for

non-Hodgkin's lymphoma (NHL) and breast cancer. She has presented at

numerous national and international conferences and published her work

widely.

-- Jacob V. Maizel, Jr., Ph.D., whose distinguished career spans nearly

40 years in research on protein and RNA structure. From 1983 to 2005,

he was a laboratory chief at the National Cancer Institute. His

research focused on the use of high performance computing to discover

important structural features of RNA. His work in developing

graphical methods for understanding structure, organization and

evolution of genes led to the U.S. Public Health Service Superior

Award in 1982. He is a
'/>"/>